Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 54

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 54
---
 be costlier than it expects, and NewGenIvf may not
be able to increase its revenue enough to offset its increased operating expenses. NewGenIvf may incur significant losses in the future
for a number of reasons, including the other risks described herein, and unforeseen expenses, difficulties, complications and delays,
and other unknown events. If NewGenIvf is unable to sustain profitability, the value of its business and common stock may significantly
decrease.

NewGenIvf’s future revenue may not grow at the rates it historically has, or at all.

NewGenIvf has experienced
growth since its business operations started in 2014. Revenue and NewGenIvf’s client base may not grow at the same rates they historically
have, or they may decline in the future. NewGenIvf’s future growth will depend, in part, on its ability to:

| ● | continue to attract new                   
 clients and/or maintain existing clients; |

| ● | price its solutions and                                                                                                          
 services effectively so that it is able to attract new clients, expand sales to its existing clients and maintain profitability; |

| ● | provide its clients with                                                
 client support that meets their needs, including through dedicated PNs; |

| ● | maintain successful collection     
 of applicable receivable balances; |

| ● | retain and maintain relationships                      
 with high-quality and respected fertility specialists; |

<div align='center'>31</div>

| ● | attract and retain highly                       
 qualified personnel to support all clients; and |

| ● | increase awareness of its                              
 brand and successfully compete with other competitors. |

NewGenIvf may not successfully
accomplish all or any of these objectives, which may affect its future revenue, and which makes it difficult for it to forecast its future
results of operations. In addition, if the assumptions that NewGenIvf uses to plan its business are incorrect or change in reaction to
changes in its market, it may be difficult for it to maintain profitability. NewGenIvf’s shareholders should not rely on its revenue
for any prior quarterly or annual periods as any indication of its future revenue or revenue growth.

In addition, NewGenIvf expects
to continue to expend substantial financial and other resources on:

| ● | sales and marketing; |

| ● | technology infrastructure,                                                               
 including systems architecture, scalability, availability, performance and security; and |

| ● | general administration,                                                                   
 including increased legal and accounting expenses associated with being a public company. |

These investments may